{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:25:33Z","timestamp":1792110333650,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03152-3","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T14:48:10Z","timestamp":1714574890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The effect of adjuvant Mitomycin C during vitrectomy on functional and anatomical outcomes in patients with severe diabetic tractional retinal detachment"],"prefix":"10.1007","volume":"44","author":[{"given":"Ihsan Gokhan","family":"Gurelik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin Baran","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,1]]},"reference":[{"issue":"10","key":"3152_CR1","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/s0161-6420(88)33014-9","volume":"95","author":"The Diabetic Retinopathy Vitrectomy Study Research Group","year":"1988","unstructured":"The Diabetic Retinopathy Vitrectomy Study Research Group (1988) Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision; clinical application of results of a randomized trial:diabetic retinopathy vitrectomy study report 4. Ophthalmology 95(10):1321\u20131334. https:\/\/doi.org\/10.1016\/s0161-6420(88)33014-9","journal-title":"Ophthalmology"},{"key":"3152_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00417-003-0815-5","volume":"242","author":"EC La Heij","year":"2004","unstructured":"La Heij EC, Tecim S, Kessels AG, Liem AT, Japing WJ, Hendrikse F (2004) Clinical variables and their relation to visual outcome after vitrectomy in eyes with diabetic retinal traction detachment. Graefes Arch Clin Exp Ophthalmol 242:210\u2013217","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"3152_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/IIO.0000000000000021","volume":"54","author":"AD Meleth","year":"2014","unstructured":"Meleth AD, Carvounis PE (2014) Outcomes of vitrectomy for tractional retinal detachment in diabetic retinopathy. Int Ophthalmol Clin 54(2):127\u2013139","journal-title":"Int Ophthalmol Clin"},{"issue":"2","key":"3152_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/jamaophthalmol.2022.5817","volume":"141","author":"P McCullough","year":"2023","unstructured":"McCullough P, Mohite A, Virgili G, Lois N (2023) Outcomes and complications of pars plana vitrectomy for tractional retinal detachment in people with diabetes: a systematic review and meta-analysis. JAMA Ophthalmol 141(2):186\u2013195. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.5817","journal-title":"JAMA ophthalmol"},{"key":"3152_CR5","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.2147\/opth.s252285","volume":"14","author":"H Al-Khersan","year":"2020","unstructured":"Al-Khersan H, Venincasa MJ, Kloosterboer A, Sridhar J, Smiddy WE, Townsend JH et al (2020) Pars plana vitrectomy reoperations for complications of proliferative diabetic retinopathy. Clin Ophthalmol (Auckland, NZ) 14:1559\u20131563. https:\/\/doi.org\/10.2147\/opth.s252285","journal-title":"Clin ophthalmol (Auckland, NZ)"},{"issue":"4","key":"3152_CR6","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/eye.2011.348","volume":"26","author":"B Gupta","year":"2012","unstructured":"Gupta B, Wong R, Sivaprasad S, Williamson TH (2012) Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice. Eye (London, England) 26(4):576\u2013582. https:\/\/doi.org\/10.1038\/eye.2011.348","journal-title":"Eye (London, England)"},{"issue":"3","key":"3152_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00417-010-1506-7","volume":"249","author":"MM Farouk","year":"2011","unstructured":"Farouk MM, Naito T, Sayed KM, Nagasawa T, Katome T, Radwan G et al (2011) Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 249(3):369\u2013376. https:\/\/doi.org\/10.1007\/s00417-010-1506-7","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"issue":"5","key":"3152_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/00006982-199909000-00002","volume":"19","author":"Y Le Mer","year":"1999","unstructured":"Le Mer Y, Korobelnik JF, Morel C, Ullern M, Berrod JP (1999) TPA-assisted vitrectomy for proliferative diabetic retinopathy: results of a double-masked, multicenter trial. Retina (Philadelphia, Pa) 19(5):378\u2013382. https:\/\/doi.org\/10.1097\/00006982-199909000-00002","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"9","key":"3152_CR9","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/eye.2015.114","volume":"29","author":"K Ghasemi Falavarjani","year":"2015","unstructured":"Ghasemi Falavarjani K, Modarres M, Hadavandkhani A, Karimi MA (2015) Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy. Eye 29(9):1199\u20131203. https:\/\/doi.org\/10.1038\/eye.2015.114","journal-title":"Eye"},{"key":"3152_CR10","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00592-019-01357-y","volume":"56","author":"M Iglicki","year":"2019","unstructured":"Iglicki M, Zur D, Fung A, Gabrielle P-H, Lupidi M, Santos R et al (2019) Tractional diabetic retinal detachment surgery with co-adjuvant intravitreal dexamethasone implant: the tradition study. Acta Diabetol 56:1141\u20131147","journal-title":"Acta Diabetol"},{"key":"3152_CR11","volume-title":"The anticancer drugs","author":"WB Pratt","year":"1994","unstructured":"Pratt WB (1994) The anticancer drugs. Oxford University Press, USA"},{"issue":"2","key":"3152_CR12","first-page":"449","volume":"39","author":"JG Crowston","year":"1998","unstructured":"Crowston JG, Akbar AN, Constable PH, Occleston NL, Daniels JT, Khaw PT (1998) Antimetabolite-induced apoptosis in Tenon\u2019s capsule fibroblasts. Investig Ophthalmol Vis Sci 39(2):449\u2013454","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"3152_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1001\/archopht.1993.01090020117035","volume":"111","author":"PT Khaw","year":"1993","unstructured":"Khaw PT, Doyle JW, Sherwood MB, Grierson I, Schultz G, McGorray S (1993) Prolonged localized tissue effects from 5-minute exposures to fluorouracil and Mitomycin C. Arch Ophthalmol 111(2):263\u2013267. https:\/\/doi.org\/10.1001\/archopht.1993.01090020117035","journal-title":"Arch ophthalmol"},{"issue":"8","key":"3152_CR14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/s41433-019-0408-0","volume":"33","author":"A Assi","year":"2019","unstructured":"Assi A, Khoueir Z, Helou C, Fakhoury H, Cherfan G (2019) Intraocular application of Mitomycin C to prevent proliferative vitreoretinopathy in perforating and severe intraocular foreign body injuries. Eye 33(8):1261\u20131270","journal-title":"Eye"},{"issue":"6","key":"3152_CR15","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1177\/1120672120976038","volume":"31","author":"G G\u00fcrelik","year":"2021","unstructured":"G\u00fcrelik G, S\u00fcl S, \u00dc\u00e7g\u00fcl AY (2021) Intraocular Mitomycin C use in the treatment and prophylaxis of proliferative vitreoretinopathy in severe traumatic retinal detachments. Eur J Ophthalmol 31(6):3284\u20133293","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"3152_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.37845\/ret.vit.2022.31.66","volume":"31","author":"G Gurelik","year":"2022","unstructured":"Gurelik G, Korkmaz S, Uyar Gocun P, Sul S (2022) Evaluation the safety of a new intraocular Mitomycin C application technique in the rabbit. Ret-Vit 31(4):387\u2013393. https:\/\/doi.org\/10.37845\/ret.vit.2022.31.66","journal-title":"Ret-Vit"},{"issue":"2","key":"3152_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/eye.1993.58","volume":"7","author":"A Garner","year":"1993","unstructured":"Garner A (1993) Histopathology of diabetic retinopathy in man. Eye 7(2):250\u2013253","journal-title":"Eye"},{"key":"3152_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.preteyeres.2015.07.005","volume":"51","author":"JC Pastor","year":"2016","unstructured":"Pastor JC, Rojas J, Pastor-Idoate S, Di Lauro S, Gonzalez-Buendia L, Delgado-Tirado S (2016) Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences. Prog Retin Eye Res 51:125\u2013155","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"3152_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40942-018-0110-6","volume":"4","author":"A Mirshahi","year":"2018","unstructured":"Mirshahi A, Lashay A, Mehrabi Bahar MR, Abrishami M (2018) Consequences of inadvertent intravitreal Mitomycin C injection. Int J Ret Vit 4(1):7. https:\/\/doi.org\/10.1186\/s40942-018-0110-6","journal-title":"Int J Ret Vit"},{"key":"3152_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3389\/fendo.2020.00591","volume":"11","author":"F Gui","year":"2020","unstructured":"Gui F, You Z, Fu S, Wu H, Zhang Y (2020) endothelial dysfunction in diabetic retinopathy. Front Endocrinol 11:591. https:\/\/doi.org\/10.3389\/fendo.2020.00591","journal-title":"Front Endocrinol"},{"issue":"13","key":"3152_CR21","doi-asserted-by":"publisher","first-page":"7142","DOI":"10.3390\/ijms22137142","volume":"22","author":"SSR Iyer","year":"2021","unstructured":"Iyer SSR, Lagrew MK, Tillit SM, Roohipourmoallai R, Korntner S (2021) The vitreous ecosystem in diabetic retinopathy: insight into the patho-mechanisms of disease. Int J Mol Sci 22(13):7142","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3152_CR22","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1167\/iovs.16-19798","volume":"57","author":"K Tamaki","year":"2016","unstructured":"Tamaki K, Usui-Ouchi A, Murakami A, Ebihara N (2016) Fibrocytes and fibrovascular membrane formation in proliferative diabetic retinopathy. Investig Ophthalmol Vis Sci 57(11):4999\u20135005. https:\/\/doi.org\/10.1167\/iovs.16-19798","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3152_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.exer.2015.04.004","volume":"142","author":"S Roy","year":"2016","unstructured":"Roy S, Amin S, Roy S (2016) Retinal fibrosis in diabetic retinopathy. Exp Eye Res 142:71\u201375. https:\/\/doi.org\/10.1016\/j.exer.2015.04.004","journal-title":"Exp Eye Res"},{"issue":"5","key":"3152_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3109\/02713683.2012.661114","volume":"37","author":"J Zhou","year":"2012","unstructured":"Zhou J, Wang S, Xia X (2012) Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Curr Eye Res 37(5):416\u2013420","journal-title":"Curr Eye Res"},{"key":"3152_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/opth.s235757","volume":"14","author":"AM Abdelhadi","year":"2020","unstructured":"Abdelhadi AM, Helaly HA, Abuelkeir A (2020) Evaluation of retinal detachment after diabetic vitrectomy: causes and ways of management. Clin Ophthalmol (Auckland, NZ) 14:53\u201360. https:\/\/doi.org\/10.2147\/opth.s235757","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"12","key":"3152_CR26","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.4103\/ijo.IJO_1217_18","volume":"66","author":"MW Stewart","year":"2018","unstructured":"Stewart MW, Browning DJ, Landers MB (2018) Current management of diabetic tractional retinal detachments. Indian J Ophthalmol 66(12):1751\u20131762. https:\/\/doi.org\/10.4103\/ijo.IJO_1217_18","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"3152_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/08820538.2017.1353832","volume":"33","author":"GL Yau","year":"2018","unstructured":"Yau GL, Silva PS, Arrigg PG, Sun JK (2018) Postoperative complications of pars plana vitrectomy for diabetic retinal disease. Semin Ophthalmol 33(1):126\u2013133. https:\/\/doi.org\/10.1080\/08820538.2017.1353832","journal-title":"Semin ophthalmol"},{"issue":"5","key":"3152_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1177\/112067210301300508","volume":"13","author":"J Jonas","year":"2003","unstructured":"Jonas J, S\u00f6fker A, Degenring R (2003) Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 13(5):468\u2013473","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"3152_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar420","volume":"4","author":"ES Chan","year":"2002","unstructured":"Chan ES, Cronstein BN (2002) Molecular action of methotrexate in inflammatory diseases. Arthritis Res Ther 4(4):1\u20138","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3152_CR30","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ophtha.2011.12.015","volume":"119","author":"SR Taylor","year":"2012","unstructured":"Taylor SR, Habot-Wilner Z, Pacheco P, Lightman S (2012) Intravitreal methotrexate in uveitis. Ophthalmol 119(4):878\u2013879. https:\/\/doi.org\/10.1016\/j.ophtha.2011.12.015","journal-title":"Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03152-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03152-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03152-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:48:53Z","timestamp":1741880933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03152-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3152"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03152-3","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"assertion":[{"value":"28 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Gazi University (2022\u20131150).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"210"}}